Distributors, manufacturers, clinical partners, research institutions, and press inquiries — we read every message and respond personally.
Veos operates with a small, senior team. Inquiries reach our leadership directly — not a filtered intake queue.
For the fastest response, please indicate the nature of your inquiry in the subject line (distribution, licensing, manufacturing, research, press, or careers).
We typically respond within two business days. For urgent matters, please email our Madrid office directly.
Regional distribution, retail and clinical channels, and direct-to-consumer e-commerce partnerships for our commercial ophthalmic portfolio.
Email our teamCo-development, in-licensing, or regional licensing of our innovative pipeline products: ThymoTropin™, BioPropello™, OliQuell™, VEOX-PRESERV™.
Email our teamInvestor relations, governance documentation, IP portfolio discussions, and capital strategy under appropriate confidentiality.
Email our teamVeos operates from offices in central Madrid, with manufacturing and distribution partnerships across Spain and the broader European Union.
Our Madrid location supports rapid coordination with EU regulators, Spanish and European research institutions, and our growing network of distribution, clinical, and commercial partners.
Veos partners with distributors, manufacturers, and research institutions worldwide. Tell us about your work, and we'll respond personally.
info@veospharma.com